SCB-2019

N/A

Report date: 2024/11/24 20:00:04

Base Information

Drug NameSCB-2019
Drug Alias NameSCB 2019 (CpG 1018/Alum)S-三聚体 COVID-19新冠疫苗SCB-2019SCB 2019 (CpG 1018/Alum)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUkrainePhilippines +[8] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPending
Originator CompaniesClover Biopharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesD'Or Institute For Research And EducationClover Biopharmaceuticals Aus Pty LtdClover Biopharmaceuticals Ltd
Inactive CompaniesZhejiang Clover Biopharmaceuticals Inc
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A